Astellas Pharma expands portfolio by acquiring Universal Cells

16-02-2018

Astellas Pharma expands portfolio by acquiring Universal Cells

posteriori / iStockphoto.com

Japan-based Astellas Pharma has acquired US-based Universal Cells in a move that will allow it to develop universal donor cell technology.


Astellas Pharma, Universal Cells, Universal Donor Cell technology, protein, bacteria, human leukocyte antigen, Claudia Mitchell, Yoshihiko Hatanaka, acquis

LSIPR